These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 212306)

  • 1. Human platelet protein kinases in diabetic retinopathy.
    Kranias G; Kranias E; Dobbie GJ; Jungmann RA; Edwards BK; Eppenberger U
    FEBS Lett; 1978 Aug; 92(2):357-60. PubMed ID: 212306
    [No Abstract]   [Full Text] [Related]  

  • 2. [Cyclic AMP-dependent protein kinase in blood platelets of rats: activation by prostaglandin E-1].
    Coquil JF; Dupuis M; Hamet P
    Union Med Can; 1977 Apr; 106(4):457-64. PubMed ID: 193227
    [No Abstract]   [Full Text] [Related]  

  • 3. Proceedings: The isolation procedure and some characteristics of c-AMP dependent protein kinases of human blood platelets.
    Kahlé LH; König BW; ten Cate JW
    Thromb Diath Haemorrh; 1975 Nov; 34(2):559. PubMed ID: 173038
    [No Abstract]   [Full Text] [Related]  

  • 4. Concentration and regulation of cyclic nucleotides, cyclic-nucleotide-dependent protein kinases and one of their major substrates in human platelets. Estimating the rate of cAMP-regulated and cGMP-regulated protein phosphorylation in intact cells.
    Eigenthaler M; Nolte C; Halbrügge M; Walter U
    Eur J Biochem; 1992 Apr; 205(2):471-81. PubMed ID: 1315268
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Subcellular distribution of cyclic AMP-dependent protein kinase activity and of cyclic AMP-binding proteins in human platelets. Modification by Ca2+-dependent proteolysis.
    Salama SE; Haslam RJ
    FEBS Lett; 1981 Aug; 130(2):230-4. PubMed ID: 6269890
    [No Abstract]   [Full Text] [Related]  

  • 6. [cAMP-dependent protein kinase in human platelets and effect of prostaglandin E1 on its endogenous substrates (author's transl)].
    Yamanaka M; Kume S; Kariya T; Tanabe A
    Nihon Ketsueki Gakkai Zasshi; 1979 Jun; 42(3):541-2. PubMed ID: 227216
    [No Abstract]   [Full Text] [Related]  

  • 7. Effects of prostaglandin E1 on protein kinase activity and endogenous phosphorylation of intact human platelets.
    Kariya T; Kume S; Tanabe A; Kaneko T; Yamanaka M; Oda T
    Biochem Pharmacol; 1979 Sep; 28(18):2747-51. PubMed ID: 227413
    [No Abstract]   [Full Text] [Related]  

  • 8. Regulation of human platelet myosin light chain kinase by the catalytic subunit of cyclic AMP-dependent protein kinase.
    Hathaway DR; Eaton CR; Adelstein RS
    Nature; 1981 May; 291(5812):252-6. PubMed ID: 6894484
    [No Abstract]   [Full Text] [Related]  

  • 9. The effect of ADP, calcium and some inhibitors of platelet aggregation on protein phosphokinases from human blood platelets.
    Bishop GA; Rozenberg MC
    Biochim Biophys Acta; 1975 Mar; 384(1):112-9. PubMed ID: 165830
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Status of platelets in complicated and uncomplicated diabetes mellitus.
    Malhotra KC; Arya RK; Chugh SN; Singla BB
    Angiology; 1982 Jun; 33(6):410-7. PubMed ID: 7091771
    [No Abstract]   [Full Text] [Related]  

  • 11. Activation of cyclic GMP-binding and cyclic AMP-specific phosphodiesterases of rat platelets by a mechanism involving cyclic AMP-dependent phosphorylation.
    Tremblay J; Lachance B; Hamet P
    J Cyclic Nucleotide Protein Phosphor Res; 1985; 10(4):397-411. PubMed ID: 2411769
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Abnormal platelet function in diabetes mellitus (author's transl)].
    Kitazawa A
    Nihon Ronen Igakkai Zasshi; 1982 Mar; 19(2):175-82. PubMed ID: 6213799
    [No Abstract]   [Full Text] [Related]  

  • 13. Octimibate, a potent non-prostanoid inhibitor of platelet aggregation, acts via the prostacyclin receptor.
    Merritt JE; Hallam TJ; Brown AM; Boyfield I; Cooper DG; Hickey DM; Jaxa-Chamiec AA; Kaumann AJ; Keen M; Kelly E
    Br J Pharmacol; 1991 Jan; 102(1):251-9. PubMed ID: 1710526
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adenosine cyclic 3',5'-monophosphate-dependent protein kinase from human platelets.
    Booyse FM; Marr J; Yang DC; Guiliani D; Rafelson ME
    Biochim Biophys Acta; 1976 Jan; 422(1):60-72. PubMed ID: 174739
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metabolic approaches to studies on diabetic microangiopathy.
    Waitzman MB; Colley AM; Nardelli-Olkowska K
    Diabetes; 1977 May; 26(5):510-7. PubMed ID: 192618
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enhancement of GTP gamma S-binding activity by cAMP-dependent phosphorylation of a filamin-like 250 kDa membrane protein in human platelets.
    Yada Y; Okano Y; Nozawa Y
    Biochem Biophys Res Commun; 1990 Oct; 172(1):256-61. PubMed ID: 2171520
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of the protein kinase activities of human platelet supernatant and particulate fractions.
    Salama SE; Haslam RJ
    Biochem J; 1984 Mar; 218(2):285-94. PubMed ID: 6324754
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of canine spontaneous diabetes mellitus with aspirin.
    Waitzman MB; Cornelius LM; Evatt BL
    Metab Pediatr Ophthalmol; 1980; 4(3):151-4. PubMed ID: 6256592
    [No Abstract]   [Full Text] [Related]  

  • 19. The pharmacology of aldose reductase inhibitors.
    Kador PF; Robison WG; Kinoshita JH
    Annu Rev Pharmacol Toxicol; 1985; 25():691-714. PubMed ID: 3923907
    [No Abstract]   [Full Text] [Related]  

  • 20. Role of cyclic AMP in platelet function.
    Salzman EW; Weisenberger H
    Adv Cyclic Nucleotide Res; 1972; 1():231-47. PubMed ID: 4353170
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.